Steven Daly

Prior to joining Inmedix, Steven was part of the executive management team of Light Sciences Oncology, a private venture-backed biotechnology company that raised over $250 Million to develop a combinational product (drug and device) for the treatment of cancer and other indications. Over his 17 years at Light Sciences Oncology Steven held positions with escalating responsibility from design engineering, product development, non-clinical research, business development and licensing, market research, and corporate strategy and development. He was intimately involved in the growth of Light Sciences from the startup phase through late stage clinical testing and eventual out-licensing of the technology. Light Sciences investigated and researched its proprietary platform technology in 7 Phase 1 Studies, 5 Phase 2 Studies, and 2 Phase 3 Studies within 3 separate IND’s. Steven holds a B.S. in Materials Science Engineering (Ceramic Engineering), M.S. in Bioengineering (Medical Engineering), and an M.B.A. from the University of Washington.